Vsiqq
Brand Name: Vsiqq
Generic Name: Brolucizumab
Active
Registration Number
BR-1397
Dosage Form
Solution for Injection (Intravitreal)
Issuance Date
April 1, 2022
Expiry Date
April 1, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength120 mg/mL (27.6 mg/0.23 mL)
PackagingSingle use 0.23 mL in 2 mL Ph. Eur. Type I colourless glass vial with grey rubber stopper and an aluminum seal with violet flip-off cap +1 1/2" 18G filter needle in a soft blister
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineovascularization Agent
A
Application
Monitored Release (MR)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
BrolucizumabActive
Monograph: Brolucizumab